160 related articles for article (PubMed ID: 9778265)
1. Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.
Wintzen AR; Plomp JJ; Molenaar PC; van Dijk JG; van Kempen GT; Vos RM; Wokke JH; Vincent A
Ann Neurol; 1998 Oct; 44(4):657-64. PubMed ID: 9778265
[TBL] [Abstract][Full Text] [Related]
2. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
[TBL] [Abstract][Full Text] [Related]
3. Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel.
Engel AG; Uchitel OD; Walls TJ; Nagel A; Harper CM; Bodensteiner J
Ann Neurol; 1993 Jul; 34(1):38-47. PubMed ID: 7685992
[TBL] [Abstract][Full Text] [Related]
4. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.
Ruff RL; Lennon VA
Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554
[TBL] [Abstract][Full Text] [Related]
5. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
6. Congenital myasthenia gravis in 13 smooth fox terriers.
Miller LM; Lennon VA; Lambert EH; Reed SM; Hegreberg GA; Miller JB; Ott RL
J Am Vet Med Assoc; 1983 Apr; 182(7):694-7. PubMed ID: 6841251
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
8. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
Burres SA; Crayton JW; Gomez CM; Richman DP
Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
[TBL] [Abstract][Full Text] [Related]
9. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
[TBL] [Abstract][Full Text] [Related]
11. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
Engel AG; Lambert EH; Gomez MR
Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
Elias SB; Appel SH
Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
[TBL] [Abstract][Full Text] [Related]
13. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
[TBL] [Abstract][Full Text] [Related]
14. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
15. Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
Farrugia ME; Kennett RP; Newsom-Davis J; Hilton-Jones D; Vincent A
Muscle Nerve; 2006 Apr; 33(4):568-70. PubMed ID: 16382443
[TBL] [Abstract][Full Text] [Related]
16. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel.
Engel AG; Lambert EH; Mulder DM; Torres CF; Sahashi K; Bertorini TE; Whitaker JN
Ann Neurol; 1982 Jun; 11(6):553-69. PubMed ID: 6287911
[TBL] [Abstract][Full Text] [Related]
17. Is excitation-contraction coupling impaired in myasthenia gravis?
Nakata M; Kuwabara S; Kawaguchi N; Takahashi H; Misawa S; Kanai K; Tamura N; Sawai S; Motomura M; Shiraishi H; Takamori M; Maruta T; Yoshikawa H; Hattori T
Clin Neurophysiol; 2007 May; 118(5):1144-8. PubMed ID: 17307394
[TBL] [Abstract][Full Text] [Related]
18. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
19. [Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)].
Morel E; Raimond F; Goulon-Goëau C; Berrih S; Vernet-Der-Garabedian B; Harb J; Bach JF
Nouv Presse Med; 1982 May; 11(24):1849-54. PubMed ID: 7110933
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Díaz-Manera J; Rojas-García R; Gallardo E; Juárez C; Martínez-Domeño A; Martínez-Ramírez S; Dalmau J; Blesa R; Illa I
Nat Clin Pract Neurol; 2007 Jul; 3(7):405-10. PubMed ID: 17611489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
